| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 376.296 | 442.431 | 375.304 | 240.542 | 286.113 | 243.388 | 379.160 | 410.523 | 540.175 | 575.767 |
| Total Income - EUR | 376.746 | 442.435 | 376.929 | 240.672 | 286.114 | 243.388 | 384.766 | 411.362 | 540.175 | 575.789 |
| Total Expenses - EUR | 376.459 | 435.772 | 396.082 | 245.708 | 251.918 | 224.020 | 351.455 | 431.515 | 525.485 | 603.389 |
| Gross Profit/Loss - EUR | 287 | 6.663 | -19.153 | -5.036 | 34.196 | 19.367 | 33.310 | -20.153 | 14.690 | -27.601 |
| Net Profit/Loss - EUR | 287 | 5.518 | -24.425 | -7.443 | 31.335 | 17.109 | 29.462 | -24.267 | 8.361 | -27.601 |
| Employees | 4 | 4 | 3 | 3 | 3 | 2 | 2 | 3 | 3 | 3 |
Check the financial reports for the company - Biocris Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 29.506 | 27.712 | 34.231 | 31.591 | 27.481 | 23.880 | 24.041 | 21.769 | 40.798 | 97.078 |
| Current Assets | 16.207 | 9.765 | 24.337 | 9.106 | 7.996 | 8.125 | 6.759 | 14.210 | 25.615 | 18.009 |
| Inventories | 0 | 609 | 907 | 450 | 1.815 | 0 | 584 | 911 | 2.142 | 1.900 |
| Receivables | 4.509 | 7.203 | 12.169 | 8.567 | 6.083 | 3.531 | 5.465 | 12.542 | 10.247 | 12.906 |
| Cash | 11.697 | 1.953 | 11.262 | 89 | 99 | 4.593 | 710 | 756 | 13.227 | 3.204 |
| Shareholders Funds | -97.454 | -81.910 | -104.949 | -110.455 | -76.981 | -58.413 | -27.655 | -52.008 | -43.489 | -70.847 |
| Social Capital | 45 | 45 | 44 | 54 | 53 | 52 | 51 | 51 | 51 | 50 |
| Debts | 143.715 | 119.406 | 163.576 | 151.210 | 112.515 | 90.474 | 58.510 | 88.503 | 109.902 | 186.830 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4631 - 4631" | |||||||||
| CAEN Financial Year |
4631
|
|||||||||
Comments - Biocris Srl